ORAMED PHARMACEUTICALS INC. (ORMP) Net margin 2016–2025
ORAMED PHARMACEUTICALS INC. (ORMP) net profit margin by fiscal year — reported net income divided by reported revenue.
3202.5%FY2025 · since FY2016: -1710.5% → 3202.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 3202.5% | — |
| FY2023 | 379.7% | +1732.3 pp |
| FY2022 | -1352.6% | -502.1 pp |
| FY2021 | -850.5% | -425.7 pp |
| FY2020 | -424.8% | +106.3 pp |
| FY2019 | -531.1% | -11.4 pp |
| FY2018 | -519.7% | -93.0 pp |
| FY2017 | -426.7% | +1283.7 pp |
| FY2016 | -1710.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice